Constipation abdominal pain

HMG-CoA reductase inhibitors are usually well tolerated. Adverse reactions, when they do occur, are often mild and transient and do not require discontinuing therapy. The more common adverse reactions include nausea, vomiting, constipation, abdominal pain or cramps, and... 

Contact the primary health care provider if the following occur nausea, vomiting, anorexia, constipation, abdominal pain, dry mouth, thirst, or polyuria (symptoms of hypercalcemia). 

Atorvastatin 1 0, 20, 40, 80 mg tablets 1 0 to 80 mg once daily (at any time of day) Most frequent side effects are constipation, abdominal pain, diarrhea, dyspepsia, and nausea. Statins... 

Symptoms of iead toxicity include gastrointestinal effects, such as vomiting, constipation, abdominal pain, and appetite loss, as well as neurologic effects, which manifest in children as decreased attention span, behavioral problems, and apparent learning disorders. 

Dizziness, constipation, abdominal pain, weakness, fatigue, cough, impotence Rare (less than 1 %)... 

Constipation, abdominal pain, anorexia, bone pain, pharyngitis, dizziness, rash, dry mouth, peripheral edema, pelvic pain, depression, chest pain, paresthesia... 

Peripheral or sensory neuropathy (usually occurs in hands, feet, perioral area, and throat but may present as jaw spasm, abnormal tongue sensation, eye pain, chest pressure, or difficulty walking, swallowing, orwriting), nausea (64%), fatigue, diarrhea, vomiting, constipation, abdominal pain, fever, anorexia Occasional (14%-10%)... 

The most common side effects are headache, dyspepsia, nausea, constipation, abdominal pain, somnolence, and EPS. Ratings of parkinsonism and akathisia with ziprasidone, 120 mg/day, did not differ from those with placebo. Although dizziness has been reported, rates of orthostatic hypotension have not differed from rates associated with placebo in controlled clinical trials. 

Constipation, abdominal pain and fullness that can be reduced by warmth. 

Cold is a Yin pathogenic factor. It has a contracting nature and can easily injure the Yang. When internal cold accumulates in the intestines, the Yang fails to spread warmth and Qi and is unable to transform and transport food, resulting in Qi stagnation. All of these cause constipation, abdominal pain, distension and fullness, reduced appetite, cold limbs and tiredness. 

This formula is able to warm the Yang and disperse the cold, promote bowel movement and reduce the accumulation. It is used for treating cold accumulation with undigested food in the intestines. Patients suffer from constipation, abdominal pain and hypochondriac pain, have cold extremities, a white, sticky tongue coating and a wiry, tight pulse. 

Features include muscle weakness and cramps, paraesthesia, nausea, vomiting, constipation, abdominal pain, polyuria, polydipsia, depression, confusion and psychosis. Hypokalaemia may cause brady/tachyarrhythmias, hypotension, respiratory failure, ileus and altered mental state. It also increases the toxicity of cardiac glycosides. There are several associated disease states (e.g. diarrhoea, vomiting, renal tubular acidosis types I and II, hypomagnesaemia, Conn s syndrome, Cushing s disease, Gitelman s syndrome, villous adenoma, pyloric stenosis, intestinal fistulae). 

Nausea, constipation, abdominal pain, weight gain... 

In occupationally exposed humans, chloracne, dermal effects and liver damage are the most common health effects. Some cases with fatal outcome have been reported. Symptoms of PCN poisoning include jaundice, constipation, abdominal pain, abdominal distension, anorexia, nausea, vomiting, anemia, skin problems, eye irritation, headache, fatigue and vertigo. Some of the toxic effects persisted for a long period after the exposure had ceased. In severe cases the patients died [1, 27, 264-266], Studies of experimentally induced chloracne show that tetra-, penta-, and hexaCNs have acnegenic properties when applied on the human skin [263,267]. 

The most frequent adverse effects of dextropropoxyphene are dizziness, sedation, and nausea and vomiting. Other reported effects include constipation, abdominal pain, skin rashes, light-headedness, headache, weakness, euphoria, dysphoria, minor reversible visual disturbances, and liver dysfunction (1). 

Anorexia, nausea and vomiting, and diarrhea are generally mild after the administration of conventional doses of etoposide and teniposide. Stomatitis is uncommon and mucositis starts to be more severe in patients who receive intravenous doses of etoposide up to 1000 mg/m. Gastrointestinal toxicity after topotecan is generally mild to moderate. Under 10% of patients complain of grade 3/4 nausea and vomiting, diarrhea or constipation, abdominal pain, or stomatitis. Mucositis is uncommon and mild after intravenous topotecan. 

The features of vinca alkaloid-induced polyneuropathy include early loss of tendon reflexes at the ankles and distal paresthesia, followed by loss of touch, pain, and vibration sensations. Other symptoms include headache, malaise, weakness, dizziness, severe face and jaw pain, and vocal cord paralysis. The first symptoms usually occur a few days after drug administration (36). Gastrointestinal discomfort, particularly constipation, abdominal pain, and adynamic ileus, can occur through an autonomic neuropathy (5,48). 

Tannic acid is moderately toxic by the inhalation and ingestion exposure pathways. Acute, high-dose ingestion and absorption may cause nausea, vomiting, constipation, abdominal pain, and liver damage. Severe intoxications may result in centralobular liver necrosis. 

Hot flashes low emetogenic potential diarrhea, constipation, abdominal pain headache back pain and myalgia pharyngitis dizziness insomnia depression... 

The patient may complain of back pain, fatigue, bloating, constipation, abdominal pain, urinary urgency, nausea, or weight change. 

Systemic and local immune responses, humoral and cellular, are mounted by the host but these are not associated with host protection. Necrosis of Peyer s patches, which may lead to intestinal perforation, is attributed to interaction of bacterial factors and host immune response. It is also interest that in typhoid fever there is no strong association with HIV infection, whereas in HIV infection there is an increased incidence of non-typhi Salmonella infection. Headache, pharyngitis and arthralgia may be present. Gastrointestinal symptoms are usually constipation, abdominal pain and tenderness. Other symptoms which may occur are diarrhea, the pea soup type containing inflammatory mononuclear cells. The biliary tree and liver is involved presenting cholecystitis and hepatitis. Splenomegaly may develop. 

For spleen vacuity with cold accumulation and constipation, abdominal pain, chilled extremities, and a deep, wiry pulse, subtract Asarum and add Radix Panacis Ginseng Ren Shen), mix-fried Radix Glycyrrhizae Zhi Gan Gao), and dry Rhizoma Zingiberis Gan Jiang). This results in Wen Pi Tang (Warm the Spleen Decoction). 

Although slightly less selective than morphine, propoxyphene binds primarily to p opioid receptors and produces analgesia and other CNS effects that are similar to those seen with morphine-like opioids. It is likely that at equianalgesic doses the incidence of side effects such as nausea, anorexia, constipation, abdominal pain, and drowsiness are similar to those of codeine. 

Workers in secondary smelters, battery production, PVC stabilization production (N = 95) Median PbB = 46 (ig/dl Gl symptoms appetite loss, constipation, abdominal pain No association of PbB with Gl effects Lee et al. (2000)... 

Dmg fominlations A novel implant of buprenorphine (Probuphine ) with sustained-release technology has been evaluated in 12 subjects with opioid dependence maintained on sublingual buprenorphine [191. Most of them (92%) had at least one adverse event and 58% had events related to the insertion or removal of the implant. Other adverse events were experienced by 42% and included dizziness, constipation, abdominal pain, implant site reactions, flushing, and pallor. There were no serious events. 

Gastrointestinal A 66-year-old patient with moderate COPD gradually developed constipation, abdominal pain, and distention within a week from the initiation of indacaterol [40 ]. The symptoms were relieved two days after... 

---